Monthly Archives: May 2020

Kingman Prepares NI 43-101 Technical Report on the Mohave Project

VANCOUVER, BC / ACCESSWIRE / May 28, 2020 / Kingman Minerals Ltd. (TSXV:KGS)(FSE:47A1) ("Kingman" or the "Company") is pleased to report that the Company is currently in the process of preparing a NI43-101 compliant technical report on the Mohave Project ("Mohave").

In 2020, Burgex Mining Consultants ("Burgex") were contracted to determine accessibility of the Rosebud Mine and complete two underground sampling programs. During the prior program, Burgex was able to use ropes and ladders to assess the safety and stability of the main production shaft and lower themselves down to the 100-foot level of the abandoned mine. Below the 100ft level the shaft was blocked by debris and garbage, which Burgex was able to successfully clear during this second program in order to gain access to the 200ft level. Additional debris was blocking the shaft below the 200ft level preventing them from accessing the 250ft level.

A photo tour, videos and additional details of the first and second reconnaissance programs are available on Company website at https://kingmanminerals.com/projects/mohave-project/first-underground-program/ and https://kingmanminerals.com/projects/mohave-project/2nd-phase-underground-reconnaissance-sampling-program/

Figure 1 – Burgex examines and samples the interior of the 100ft drift level during the 1st of 2 underground programs.

Figure 2 – Burgex examines and samples the interior of the 200ft drift level during the 2nd of 2 underground programs.

Figure 3 – Longitudinal section of the Rosebud Mine (Mohave Project) with underground sampling results and locations from first and second Burgex reconnaissance programs. All values are presented in Au (g/t)/Ag (g/t).

The samples that Burgex collected were sent to ALS Laboratories in Reno, Nevada and were analyzed using the ALS method ME-GRA21 for gold and silver. This method is a fire assay method for optimal precious metal recovery. The ME-GRA21 method is described as "Au and Ag by fire assay and gravimetric finish ". This is what ALS recommends for the type samples from Rosebud.

QA/QC procedures used for this second round of underground sampling included the use of two different Au/Ag standards and one blank standard prepared by MEG, Inc. of Reno, Nevada. These standards and blank were inserted into the sample batch with the rest of the Burgex 2nd round samples. Analytical results of the standards and blank were within their respective acceptable ranges.

The results of both programs will be implemented into the NI43-101 technical report. "The Company is incredibly proud of the acquisition of the Mohave Project and our progress to date. This project has immense potential and our team has really come together to make these efforts despite the obvious challenges posed by the recent COVID concerns. Kingman intends to continue to move forward undeterred and will announce its go forward plans once the information has been finalized" stated Sandy MacDougall, Chairman and Director.

The technical information contained in this news release has been reviewed and approved by Bradley C. Peek, MSc. and Certified Professional Geologist who is a Qualified Person with respect to Kingman's Mohave Project as defined under National Instrument 43-101.

About Kingman

Kingman Minerals Ltd. is currently engaged in the business of precious metal mineral exploration for the purpose of acquiring and advancing non grass roots mineral properties located in mining friendly jurisdictions of North America.

The Mohave Project (the "Project") is located in the Music Mountains in Mohave County, Arizona and is comprised of 20 lode claims which are inclusive of the past producing Rosebud Mine (the "Rosebud"). High grade gold and silver veins were discovered in the area in the 1880's and were mined mainly in the late 20's and 30's. Underground development on the Rosebud property included a 400-foot shaft and approximately 2,500 feet of drifts, raises and crosscuts.

For further information please contact:

Sandy MacDougall, Chairman & Director
(604) 685-7720
sandyjmacdougall@gmail.com
www.kingmanminerals.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes statements regarding, among other things, the completion transactions completed in the Agreement. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, regulatory approval processes. Although Kingman believes that the assumptions used in preparing the forward-looking information in this news release are reasonable, including that all necessary regulatory approvals will be obtained in a timely manner, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Kingman disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by applicable securities laws.

SOURCE: Kingman Minerals Ltd.

ReleaseID: 591691

Eyecarrot Affirms Appointment of Dr. Leonard Press as Chief Scientific Officer

TORONTO, ON and NEW YORK, NY / ACCESSWIRE / May 28, 2020 / Eyecarrot Innovations Corp (TSXV:EYC)(QTCQB:EYCCF)(FRA:2EYA:GR] announces the appointment of Dr. Leonard Press to Chief Scientific Officer. Dr. Press has contributed to the Company as its Director of Global Education supporting the development resources available to vision professionals through Binovi Academy and the Binovi Platform. Through his appointment, he will lead the Scientific Advisory Board and all scientific development efforts including the expansion of Speed of Stereopsis, established by his predecessor Dr. Selwyn Super, who passed away earlier this year.

Dr. Leonard Press is a graduate of the Pennsylvania College of Optometry, where he was a member of the Gold Key International Optometric Honor Society. He completed his Residency program in Pediatric Optometry at The Eye Institute of the Pennsylvania College of Optometry in Philadelphia, and formerly served as Chief of the Pediatric Unit of The Eye Institute. Dr. Press was recruited to the State University of New York, State College of Optometry, to serve as Chief of the Vision Therapy Service, where he was Associate Professor of Clinical Optometry for 15 years. Patients of all ages with problems related to vision development, visual processing, learning disabilities, and dyslexia are referred to Dr. Press by a wide variety of professionals through his consulting practice in Lakewood, New Jersey. He works extensively with occupational therapists, educators, and parent groups in helping parents understand the relationship between vision and learning, and opportunities for therapy to help children succeed.

"Dr. Selwyn Super was a gentleman and scholar whose foresight helped set the scientific tone for Eyecarrot and Binovi. His vision and thought processes had a significant influence on my thinking and career, as well as on the careers of many contributors to our field. I look forward to carrying on and expanding his scientific legacy as we continue to develop the Binovi suite of concepts and products." stated Dr. Leonard Press, OD, FAAO, FCOVD

Additionally, Dr. Press has been recognized internationally for his work in the field of learning-related vision problems. He was a co-author of the Clinical Practice Guidelines in this area for the American Optometric Association and is the author of a monograph from the Optometric Extension Program on Computers and Vision Therapy Programs. He is the author of three major textbooks on vision which act as the primary reference used by therapists and doctors from around the world who are preparing for board certification in vision therapy through the College of Optometrists in Vision Development (COVD). Dr. Press served as President of the College of Optometrists in Vision Development, and formerly served on the examining board which conducts board certification. He is also a Diplomate in the Pediatric Optometry/Binocular Vision and Perception Section of the American Academy of Optometry, and the only doctor in New Jersey with specialty certification through both of these prestigious organizations.

Dr. Press served as a consultant on visual disabilities for the National Board of Medical Examiners (NBME), where he reviewed requests for test accommodations on the examinations that certifies MDs to practice Medicine in the United States. Candidates submit a request for modification of their computer monitor, extra time, or test breaks, based on supporting documentation of any visual disabilities not fully corrected by glasses or contact lenses. Many children in special education environments face similar issues in terms of Section 504 accommodations for schoolwork or standardized testing. He has lectured extensively on these subjects in the United States and abroad.

The recipient of numerous awards for his research, writing, and clinical work, Dr. Press has received the Scientific Achievement Award from the New Jersey Society in both 1995 and in 2002. He received the Skeffington Award for Excellence in Optometric Writing from the College of Optometrists in Vision Development in 1992 and was honored by his peers as Optometrist of the Year by the New Jersey Society of Optometric Physicians, previously serving as President of the organization. He was honored as the Alumnus of the Year of the Pennsylvania College of Optometry in 2003, which cited him for his outstanding contributions in the field of children's vision and vision-related learning problems.

"Our partnership with Dr. Press has already proven to be a fruitful one for both parties, and with the unfortunate passing of Dr. Selwyn Super earlier this year, we saw it fit to invite him to take his place as a key part of the continued development of the Binovi Platform. Dr. Press' credentials, accomplishments, and experience speak for themselves and will be a great asset to the Company moving forward. We look forward to continue working with Dr. Press as Binovi grows," commented Adam Cegielski, President and CEO.

The Company also announces it has retained Generation IACP Inc. ("Generation") to provide market making services with the objective of maintaining a reasonable market and improving the liquidity of its Common Shares. Under the agreement between Generation and the Company (the "Generation Agreement"), the Company has agreed to initially pay Generation a fee of C$7,500 plus applicable taxes, per month. Generation will not receive any Common Shares or options as compensation. Generation does not currently own any securities of Eyecarrot Innovations Corporation; however, Generation and its clients may acquire a direct interest in the securities of the Company. Eyecarrot Innovation Corporation and Generation are unrelated and unaffiliated entities. Generation is a member of the Investment Industry Regulatory Organization of Canada and a member firm of the Toronto Stock Exchange and the TSX Venture Exchange. The initial term of the Generation Agreement will last 6 months, and such term will be automatically renewed for subsequent 6-month periods unless terminated earlier by 30 days' prior written notice.

About Eyecarrot Innovations Corp

Eyecarrot is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

On behalf of the Board of Directors

Adam Cegielski
President | CEO

Investor Relations

Email: invest@eyecarrot.com
Toll-free: 1 (844) 866-6162
https://www.eyecarrot.com/investors/

Forward looking information

Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Eyecarrot Innovations Corp.

ReleaseID: 591747

EGF Theramed Health Announces Early Stage Due Diligence On Cash-Generating Psilocybin Assets/Clinics

VANCOUVER, BC / ACCESSWIRE / May 27, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC PINK:EVAHF)(FRA:AUHP)(the "Company") announces that it has commenced due diligence and research into additional acquisition opportunities that complement its current work in the health sciences sector. Specifically, the Company is further investigating the psilocybin and ketamine sectors, focusing on innovative care and specific dose treatments, with the overall goal of improving health and promoting human condition.

Following the Company's recent joint ventures through the acquisitions of a 40% equity interest in Green Parrot Labs Corp. ("Green Parrot") and a 30% equity interest in Pharmadelic Labs Corp. ("Pharmadelic Labs"), the Company plans to strengthen its existing vertical markets in the health sciences sector. The Company has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations and is working with Pharmadelic Labs to implement psilocybin and psychedelics extraction and processing at the Company's Las Vegas lab facilities. The Company will also continue to seek and develop products, technologies and diagnostic tools focused on hemp-derived cannabidiol.

Psilocybin microdosing is known to reduce stress, anxiety and pain without many of the side effects associated with traditional pharmacology products that have been prescribed for the same issues. Psilocybin has been decriminalized in Denver, Oakland, and Santa Cruz and the Food and Drug Administration in the United States has granted a breakthrough therapy designation for the compound. Preliminary clinical evidence indicates psilocybin may demonstrate substantial improvement over other available therapies for treatment-resistant depression.

The initiative by the Company to strengthen its health sciences business by expanding into the psilocybin and ketamine sectors is a proactive move to investigate potentially new verticals of sales and complementary assets. "We are very excited about the psilocybin and ketamine space as we feel it is very complimentary to the cannabidiol space, as both have the potential for unique health benefits. Like any business, cashflow is a key component to the success of our Company, and we will be exploring different channels within the space to create revenue," states Jay Dhaliwal, CEO of the Company.

The Company also reports that David Bentil has resigned as Chief Executive Officer and Director effective today. The Board of Directors wishes to thank Mr. Bentil for his valuable contributions to the Company during his tenure. The Board of Directors is also pleased to announce that Mr. Jay Dhaliwal, a current director of the Company, will step into the role of Chief Executive Officer.

As previously announced, the proceeds of recent private placements have and will continue to be used, in part, for marketing and investor relations activity. In addition to previously disclosed payments, the Company has recently spent USD$367,500 on strategic consultants to grow awareness, including payments of USD$300,000 to Gold Standard Media LLC and USD$67,500 to Awareness Consulting Network LLC. Both of these engagements were for advisory services for promotional activities during the month of May. The Company will continue to look at future marketing opportunities and strategic consultants to grow awareness of the Company and its activities.

ABOUT EGF THERAMED HEALTH CORP.

(CSE:TMED / OTC:EVAHF / FRANKFURT: AUHP)

EGF Theramed is a consumer technology company engaged in the provision of biomedical online services for monitoring and treating common health problems. The Company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations, as well as medical monitoring device technology. The Company is working to collaborate with other companies for medical technology, equipment protocols and laboratory standard operating procedures. Through the Company's recent joint venture acquisitions, it has begun to research psilocybin and psychedelic extraction and processing for commercialization.

FOR MORE INFORMATION PLEASE CONTACT:

EGF THERAMED HEALTH CORP.

Doug McFaul

Email: dmcfaul@emprisecapital.com

Telephone: (778) 331 8505

Website: http://www.theramedhealthcorp.com

CSE Micro-site: http://thecse.com/en/listings/technology/Theramed-Health-Corporation

US OTC Markets (OTCQB): http://www.otcmarkets.com/stock/EVAHF/news

Frankfurt Borse: https://www.boerse-frankfurt.de/equity/egf-theramed-health-corp

Disclaimers

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including with respect to: the ability of psilocybin to reduce stress, anxiety and pain without many of the side effects associated with traditional pharmacology products that have been prescribed for the same issues; the ability of psilocybin to offer a substantial improvement over other available therapies for treatment-resistant depression; and the ability of psilocybin and ketamine to improve health and promote the human condition. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: EGF Theramed Health Corp

ReleaseID: 591752

Bill Lerner – Talks About Developing a Family Business

The family enterprise was established under the name of Lerner Parking Services by Bill Lerner’s father in the 1960s

New York, NY – May 28, 2020 /MarketersMedia/ —

Bill Lerner, parking industry magnate for more than 40 years, turned iPark into one of the biggest facilities of its kind in New York City. Originally a family-owned business called Imperial Park Systems, iPark grew by implementing modern technologies and focusing on its customers. Under his leadership as owner and CEO, the company is set to continue growth and to expand into markets outside of the New York metropolitan area, paving the way into a national industry key player.

The family enterprise was established under the name of Lerner Parking Services by Bill Lerner’s father in the 1960s who ran a gas station on Center Street and saw a market opportunity in the increasing need for parking space for people who commuted by private vehicle to work in New York during the day. Once created, the business grew in parallel with the growth and expansion of the city. When Bill took over operations from his father in 1978, the company had 12 parking garages across the city and has since expanded to over 130 locations. To support the customer experience and to contribute to eco-friendly practices, iPark has partnered with Tesla Motors, Inc. and CarCharging to bring charging stations for electric and hybrid cars to over 30 garages. Computerization, passion for business, strategic planning and most importantly the dedication to provide the best service to customers have been fundamental elements of this success.

According to a Harvard Business School study, 70% of family-owned businesses are sold or fail before ever getting a chance to be handed over to a second generation. One of the main reasons is typically the fact that these types of enterprises are run by the same individuals for a long period of time and as a result are no longer able to adapt to changing shifts in customer behavior, technological progress, and the ever so evolving competitive business environment. To compete in the parking industry under these conditions, Bill Lerner had to quickly adjust to being proactive, multi-faceted, and to maintain a clear vision for the company’s growth. At the core of his strategy was developing a company that provides the best possible customer care experience using modern-day technologies, values its staff, and showcases exemplary work ethics. Mr. Lerner attributes his success to his father’s instinctual ability to understand and identify trends directly affecting the industry and instilling in him the idea that “being prepared, and avoiding conformity and complacency, were key to business survival”.

Bill Lerner graduated from the University of Colorado with a degree in Business, before officially joining the family business. In addition to being a successful entrepreneur, Mr. Lerner has established an award-winning charitable organization, Billy4Kids, working to provide shoes to underprivileged children from across the world to foster a safer environment to live and play. His achievements as an entrepreneur and devotion to charitable work have been previously featured by CNBC, The Atlantic, Radio America, 33 Voices and Leaders Magazine among others.

Bill Lerner – President and CEO of iPark: http://billlernernews.com

Billy Lerner (@billy_lerner) – Twitter: https://twitter.com/billy_lerner

Billy Lerner – Home – Facebook: https://www.facebook.com/billylernerofficial/

Contact Info:
Name: BLN
Email: Send Email
Organization: BillLernerNews.com
Website: http://billlernernews.com

Source URL: https://marketersmedia.com/bill-lerner-talks-about-developing-a-family-business/88959063

Source: MarketersMedia

Release ID: 88959063

Amika Mobile Products Selected for Testing for COVID-19 Contact Tracking by Government of Canada

OTTAWA / ACCESSWIRE / May 28, 2020 / Amika Mobile‘s situational awareness, command and control products the Amika Mobility Server (AMS) and its mobile apps including Amika®Panic and Amika®Guard that provide 2-way communications over SMS, Email, Pop-ups, Push, and Voice calls have been selected through a competitive process for a project with the Government of Canada by Innovative Solutions Canada whose objective is to drive SMEs to bring innovative solutions to government of Canada departments. The contact tracking will enable the Government of Canada to respond to the urgent requirement of enforcing its Quarantine Law and ensuring its citizens are tracked during the pandemic assisting health care workers and first responders to COVID-19 incidents and ensuring individuals are receiving critical messages from front line workers and responding to them promptly saving hundreds of thousands of personnel hours in tracking who has COVID-19 and who their direct contacts are, leveraging Amika® Situation Commander and Amika® Mapper to map them in real-time to support public safety and lessen the spread of COVID-19.

Amika Mobile has operated as an essential service during this pandemic crisis and has continued to support customers in the US and Canada leveraging our products for critical and emergency communications to their employees, customers and stakeholders during this COVID-19 pandemic, via integrations with IPAWS and AlertReady regional and national alerts and by tracking their critical employees during the pandemic.

"We are keen to work with the front line workers in collaboration with the Government of Canada testing out our award-winning and innovative life safety contact tracking solution during this critical time in history," said Amika Mobile CEO Dr. Sue Abu-Hakima.

 

Amika Mobile's AMS enables situational awareness, information sharing, rapid 2-way communications across devices and networks, and control through advanced integrations with government agency alerts and physical security systems. AMS can trigger individual, group or en masse, any layer alerts including VoIP, SMS, Pop-ups, web, overhead displays, digital signs, twitter, tickers, based on any automations including, government agency or weather alerting feeds, panic buttons, or sensor events from digital thermometers, access control, fire panels, camera systems, etc.

MarketsandMarkets forecasts the Incident and Emergency Management Market to grow from USD 107.0 billion in 2019 to USD 148.5 billion by 2024. This growth is driven by many factors including increased terrorism, workplace violence, active shooters, natural disasters, viral outbreaks and heightened need for critical and emergency communication in crisis management.

About Amika Mobile: Amika Mobile® Corporation is privately held specializing in critical and emergency communication and control. Its flagship product, the Amika® Mobility Server (AMS), addresses IoT and BYOD security and is ideal for alert/response in Smart Cities, enterprise, community, airport, sports arena, shopping center and campus where visitors may not always be pre-registered in a contacts database since the AMS can auto-discover mobile devices for emergency alert/response. AMS is an AI-based IoT 2-way platform that communicates securely over wire or mobile to ANY layer including WiFi, SMS, Email, VoIP, PA systems, Message Boards, Twitter, RSS Feeds, Facebook, etc. AMS and Amika®Panic can trigger lockdowns and alerts based on disparate events from gunshot sensors, access control, fire panels, cameras, wall-mounted, desktop or mobile panic buttons, etc. Amika® Situation Commander tracks event alert/response in real-time and displays it on Amika® Mapper. AMS delivers advisory government alerts from NOAA, IPAWS, EAS, Alert Ready in CAP /CAP-CP formats. Amika Mobile® has won 24 awards including the US GOVIES for 6 years in a row including 2020 for Best Emergency Communications Solution and also sells products through partners. Amika Mobile® is a woman-owned WeConnect Internationally certified business. See www.amikamobile.com

CONTACT:

Amika Mobile Corporation, Media Relations Contact: Sarah Goldsmith, Phone: 613-599-4445 x0 , contact@amikamobile.com Follow us on Twitter: @AmikaAlert

Amika Mobile®, Amika® and Amika®Panic Amika® Situation Commander, Amika® Mapper are registered trademarks of Amika Mobile.

SOURCE: Amika Mobile

ReleaseID: 591692

Pharmaceutical Excipients Market Demand & Analysis 2020-2027 | Reports And Data

An extensive study of the product application and services conducted by subject matter experts assessing the Pharmaceutical Excipients market will help product owners to make a wise decision.

New York, United States – May 28, 2020 /MarketersMedia/ —

The report titled Global Pharmaceutical Excipients Market is a new report published by Reports and Data. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Pharmaceutical Excipients market. New entrants and top players can use the analysis of market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Pharmaceutical Excipients market is carefully analyzed and researched by the market analysts.

The report highlights the impacts of the pandemic on the global Pharmaceutical Excipients market, along with strategies and opportunities that one can benefit from, till 2020-2027. The research study includes the latest updates about the COVID-19 impact on the Pharmaceutical Excipients sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

For Better Understanding, Download Free Sample Copy of Pharmaceutical Excipients Market Report @ https://www.reportsanddata.com/sample-enquiry-form/2713

The most influential and dominant participants of the global Pharmaceutical Excipients industry are:
Ashland Global Holdings (US), BASF SE (Germany), DuPont (US), Roquette Feres (France), Evonik Industries AG (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol Corporation (US), Croda International (UK). Innophous Holdings (US), Kerry Group (Ireland), WACKER Chemie AG (Germany).

The global Pharmaceutical Excipients market 2020 report provides definitions, classifications, Pharmaceutical Excipients industry coverage. The segregation is intended to offer the reader a brief understanding of the Pharmaceutical Excipients industry and the crucial elements that boost the Pharmaceutical Excipients industry. This permits you to comprehend the threats, drivers, opportunities, and restraints better.
Pharmaceutical Excipients market Segments:

Segmentation by Type:
• Fillers and Diluents
• Suspending and Viscosity Agents
• Coating Agents
• Binders
• Flavouring Agents and Sweeteners
• Disintegrates
• Colorants
• Lubricants and Glidants
• Others

Segmentation by Application:
• Pharmaceutical companies
• Chemical companies
• Others

In addition to corporate strategies, the Pharmaceutical Excipients market highlights important factors that act as market drivers or as market foreclosure factors, thus preventing the industry from moving forward. The report analyzes the key factors that influence the growth of the main market players and their presence in the market. Market share, production value, gross margin analysis, import and export scenario, consumption rate, and SWOT analysis are calculated for regions and countries.

Get Discount the Report @ https://www.reportsanddata.com/discount-enquiry-form/2713

Key Benefit of Pharmaceutical Excipients Report:
– Meticulous analysis of the key aspects of the market that influence the trends and future of the Pharmaceutical Excipients market. Also, the opportunities and threats in the market and weaknesses and strengths of the players operating in the market.
– Analysis of key player’s strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market.
– Global, regional, country-level market size and their forecast.
– Identification of key market players and comprehensively analyze their market share and core skills, key products, detailed financial positions, and unique selling points.
– Expert discussions and their insights on market change, current and future outlook, and factors impacting vendor’s short term and long term strategies.

Strategic Points Covered in Table of Content of Global Pharmaceutical Excipients Market:
– Chapter 1: Introduction, Segmentation, Region, Drivers, Restraints, Opportunities, Trends.
– Chapter 2: Overview, Exclusive Summary – the basic information of the Pharmaceutical Excipients Market.
– Chapter 3: Company Profile, Market Competition Scenario Analysis, Overview of Major Market Players, Displaying the Market Dynamics
– Chapter 4: Presenting the Pharmaceutical Excipients Market Factor Analysis Porters Five Forces, Market Entropy, Patent/Trademark Analysis, Supply/Value Chain, PESTEL analysis.
– Chapter 5: Displaying the by fiber type, process, application, and region 2014-2019
– Chapter 6: Evaluating the leading players of the Pharmaceutical Excipients market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
– Chapter 7: To estimate the market share held by the player s and the market segments.
– Chapter 8 & 9: Appendix, bibliography and data source
The Pharmaceutical Excipients Market Report is a valuable source of guidance for individuals and companies.

Access Full Report Description, TOC, Table of Figure, Chart, Graph, etc. @ https://www.reportsanddata.com/report-detail/pharmaceutical-excipients-market

Data Sources & Methodology:
Primary research is carried out through Email interactions, telephonic interviews, and one-on-one interviews and discussions to gain a crisp, clear, and accurate understanding of each market, category, segment, and sub-segment across geographies. Reports and Data has a strong global database comprising experts, participants, and veterans across a range of industries, verticals, sectors, and markets, through whom we validate our information/data and analysis results. A typical research interview fulfills the following functions: Provides competitive landscape, consumer trends, market growth trends, first-hand information, and analysis on market size, opportunities, outlook, etc

Contact Info:
Name: John Watson
Email: Send Email
Organization: Reports And Data
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Phone: +1-212-710-1370
Website: https://www.reportsanddata.com/

Source URL: https://marketersmedia.com/pharmaceutical-excipients-market-demand-analysis-2020-2027-reports-and-data/88959267

Source: MarketersMedia

Release ID: 88959267

Cyanocobalamin Market Growth rate, Trends and Industry Forecasts to 2027

An extensive study of the product application and services conducted by subject matter experts assessing the Cyanocobalamin market will help product owners to make a wise decision.

New York, United States – May 28, 2020 /MarketersMedia/ —

The global Cyanocobalamin Market is forecast to reach USD 210.4 Billion by 2027, according to a new report by Reports and Data. Cyanocobalamin drugs are used to treat and prevent the lack of vitamin B12 that may be caused by due to pernicious anemia, certain infections, diseases, or medications that reduce the level of Vitamin B12 absorbed from food; or a vegan diet.
An increase in the health consciousness among the consumers has boosted the demand for veganism, which has boosted the demand for vegan food among the population. A significant increase in the vegan population has increased the deficiency of certain vitamins, such as Vitamin B12. The deficiency of vitamin B12 in pure vegan products is driving the demand for the product. Cyanocobalamin is the synthetic form of vitamin B12.

This report covers the recent COVID-19 incidence and its impact on Cyanocobalamin. The pandemic has widely affected the economic scenario. This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.

To get this report with detailed market information, tables, charts, graphs, etc., reach us here @ https://www.reportsanddata.com/sample-enquiry-form/2702

Key participants Apotheca Inc., Merck KGaA, Charkit Chemical Company LLC, Johnlee Pharmaceuticals Pvt. Ltd., American Regent, Inc., Koninklijke DSM N.V., Chemkart, Bristol-Myers Squibb, Sanofi-Aventis, and Pfizer, among others.

A deficiency in the key vitamin can cause severe symptoms, including nerve damage, fatigue, neurological problems, and digestive issues, like depression and memory loss. Therefore, many people turn to vitamin B12 supplements to help meet their needs and prevent a deficiency.

Rapid urbanization and a rise in disposable income coupled with an increase in awareness regarding health issues are the factors driving the market growth during the forecast period. Rising prevalence of depression, paranoia, and memory loss is also propelling the demand for Vitamin B12. Favorable outlook towards medical nutrition will also drive the demand for the Cyanocobalamin.

For the purpose of this report, Reports and Data have segmented into the global Cyanocobalamin market on the basis of grade, form, end-use, distribution channel, and region:

Grade Outlook (Revenue, USD Million; 2016-2027)
• Food Grade
• Pharmaceutical Grade

Form Outlook (Revenue, USD Million; 2016-2027)
• Powder
• Liquid
• Capsule
• Tablets

End-Use Outlook (Revenue, USD Million; 2016-2027)
• Food Industry
• Nutraceuticals
• Pharmaceutical
• Dietary Supplements

Distribution Channel Outlook (Revenue, USD Million; 2016-2027)
• Online Retailing
• Store-based Retailing

Ask for available discounts on this report by reaching out to us at @ https://www.reportsanddata.com/discount-enquiry-form/2702

Regional Outlook (Revenue in USD Million; 2016–2026)
• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)

Further key findings from the report suggest
• In the food and beverage industry, Cyanocobalamin is used to fortify in various food and beverage products as it is tasteless and odorless, and does not impact the previous taste and odor of the food products. The demand for a fortified food product is rising in the food and beverage sector owing to rise in health awareness among the population.
• Tablet is the most commonly used type of Cyanocobalamin supplement due to the cost-effectiveness and easy packaging techniques. Tablets are highly preferred by consumers owing to their easy material packing and extended shelf life.
• Food grade materials are either safe for human consumption or it fine to come into direct contact with food products. Food contact surfaces are made of food-safe materials that are designed to withstand the environment in which they will be used. This includes exposure to sanitizing agents, cleaning compounds, and cleaning procedures.
• Growing awareness about the significance of a healthy diet in countries such as India and China is expected to drive the market in the region. The upcoming retail sector in emerging nations such as Indonesia, Malaysia, China, and India are propelling the market in the region. Support from the government to promote development initiatives is also expected to drive the market in the upcoming years.
• The primary driver for the online retailing of the Cyanocobalamin market is the better online education and targeted marketing. This has increased the ease and comfort of consumers buying online. Online sites are dedicated to products appropriate for the 50+ demographic to shop for by need. Many sites now have live chat options to instantly help out the customers with their specific questions.

To read the full report now, with industry-wide coverage, visit@ https://www.reportsanddata.com/report-detail/cyanocobalamin-market

The research report by Reports and Data analyzes and forecasts the growth of the Cyanocobalamin Market at the global and regional levels. The market has been projected in terms of volume and price for the forecast period. The report also sheds light on the various opportunities within the market.

Contact Info:
Name: John Watson
Email: Send Email
Organization: Reports And Data
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Phone: +1-212-710-1370
Website: https://www.reportsanddata.com/

Source URL: https://marketersmedia.com/cyanocobalamin-market-growth-rate-trends-and-industry-forecasts-to-2027/88959390

Source: MarketersMedia

Release ID: 88959390

Food Robotics Market Latest trends and Industry Status 2020-2027

An extensive study of the product application and services conducted by subject matter experts assessing the Food Robotics Market will help product owners to make a wise decision.

New York, United States – May 28, 2020 /MarketersMedia/ —

The report on the Global Food Robotics Market by Reports and Data report consists of the historical data, latest market trends, rules and regulations, technological advancements, new upcoming technologies, and prevalent strategies adopted by industry participants. This study also analyzes the overall market status, market share, growth rate, key market drivers, growth opportunities and challenges, risks and entry barriers, sales channels, and others.

This is the latest report, covering the current COVID-19 scenario. The Coronavirus pandemic has greatly affected the global industry. It has brought along various changes in market conditions. The rapidly changing market scenario and the initial and future assessment of the impact are covered in the research report. The report discusses all major aspects of the market with expert opinions on the current status along with a historical analysis.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.reportsanddata.com/sample-enquiry-form/2831

The report is filled with statistics and graphical representations for a better understanding of the data that is presented in a detailed chapter-wise format. Profiles of prominent market players also help predict the state and direction of the industry.

In market segmentation by manufacturers, the report covers the following companies-
Mitsubishi Electric Corporation (Japan), ABB Group (Switzerland), Kawasaki Heavy Industries Ltd. (Japan), Rockwell Automation Incorporated (U.S.), and FANUC Corporation (Japan). KUKA AG (Germany), Seiko Epson Corporation (Japan), Yaskawa Electric Corporation (Japan), Staubli International Corporation (Switzerland), Mayekawa Mfg. Co., Ltd. (Japan), Universal Robots A/S (Denmark), and Bastian Solutions Inc. (U.S.)

This category-based assessment is beneficial for the reader to capitalize on those market segments that promise positive growth in the coming years. The report also examines the Food Robotics Market on the basis of the value, cost structure, and gross revenue. The three factors are analyzed for the different product types, the companies that are primarily engaged in the manufacture of the prevalent products, and the leading regional market in terms of sales of those product types. Apart from the statistical analysis, the total sales have also been assessed for the different types, applications, and regions. The Food Robotics industry consumption in the prominent regional markets has also been examined, along with the product types and applications that are contributing significantly to the overall market share.

The segmentation included in the report is beneficial for readers to capitalize on the selection of appropriate segments for the Food Robotics sector and can help companies in deciphering the optimum business move to reach their desired business goals.

In market segmentation by types of Food Robotics, the report covers-
• Articulated
• Cartesian
• SCARA
• Parallel
• Cylindrical
• Collaborative
• Others

Buy Your Copy Now (Customized report delivered as per your specific requirement) @ https://www.reportsanddata.com/checkout-form/2831

In market segmentation by applications of the Food Robotics, the report covers the following uses-
• Palletizing
• Pick & place
• Packaging
• Repackaging
• Processing
• Others

Objectives of the study:
Our panel of expert analysts specializing in the value chain has conducted an exhaustive, industry-wide study to offer readers accurate insights into the future of the Food Robotics market and give key market players authentic information derived via both primary and secondary sources of data collection. Additionally, the report also comprises of inputs from our consultants, which can help companies make the most of the available market opportunities. It also offers a detailed breakdown of the sales of Food Robotics and the factors that could potentially influence the growth of the industry. The information provided in this report will be able to help readers capitalize on the available growth prospects.

Click here for a discount on the Food Robotics Market Report @ https://www.reportsanddata.com/discount-enquiry-form/2831

TOC highlights of the Global Food Robotics Market:
Chapter 1 analyzes the Food Robotics Introduction, product offerings, and scope, complete market overview, growth opportunities, market risks, driving forces, and others.
Chapter 2 presents a detailed study of the key manufacturers of Food Robotics, along with sales, revenue, and the price of Food Robotics.
Chapter 3 includes the competitive scenario among the major manufacturers and vendors.
Chapter 4 shows the global Food Robotics market by regions, clubbed with sales, revenue, and market share for each region, from 2016 to 2027.
Chapters 5, 6, 7, 8, and 9, study the market by region, by type, by application, and by manufacturer, with the sales, revenue, and market share based on leading countries in these regions.

Browse the full report @ https://www.reportsanddata.com/report-detail/food-robotics-market

The research report by Reports and Data analyzes and forecasts the growth of the Food Robotics Market at the global and regional levels. The market has been projected in terms of volume and price for the forecast period. The report also sheds light on the various opportunities within the market.

Contact Info:
Name: John Watson
Email: Send Email
Organization: Reports And Data
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Phone: +1-212-710-1370
Website: https://www.reportsanddata.com/

Source URL: https://marketersmedia.com/food-robotics-market-latest-trends-and-industry-status-2020-2027/88959255

Source: MarketersMedia

Release ID: 88959255

Enzymes Market Research Report By Current & Future Trends And Industry Forecast To 2026

An extensive study of the product application and services conducted by subject matter experts assessing the Enzymes Market will help product owners to make a wise decision.

New York, United States – May 28, 2020 /MarketersMedia/ —

The global Enzymes Market is forecasted to reach USD 11.03 Billion by 2026, according to a new report by Reports and Data. Enzyme market has gathered special attention in the past few years owing to its vast applications. They are utilized in food and animal feed, detergents and textiles, manufacturing industries, pharmaceuticals and biotechnology R&D, leathers and others. Applications of enzymes in the manufacturing process result in cost reduction due to less energy consumption, and better substrate activity.

The growth of the enzyme market is mainly due to the high demand for effective enzymes based pharmaceuticals. Other driving forces include an increase in demand for renewable energy sources such as biofuels, wide applications of enzymes in various industries, and a rise in prevalence of various chronic diseases such as inflammation & digestive diseases.

This report covers the recent COVID-19 incidence and its impact on Enzymes Market. The pandemic has widely affected the economic scenario. This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.reportsanddata.com/sample-enquiry-form/1252

Key participants include AB Enzymes GmbH, Advanced Enzyme Technologies Ltd., Amano Enzyme Inc., BASF SE (BASF Corporation), Codexis, Inc., DowDuPont Inc., F. Hoffmann-La Roche Ltd., Koninklijke DSM N.V., Novozymes A/S, and Thermo Fisher Scientific Inc. (Affymetrix, Inc.) among others.

North America dominates the market, followed by Europe. Asia-Pacific has the highest growth rate throughout the forecast period, owing to the high prevalence of chronic disorders, increase in disposable incomes, an increase in awareness regarding enzymes based pharmaceuticals and protein engineering techniques.

For the purpose of this report, Reports and Data have segmented global Enzymes market on the basis of Type, Source, Reaction Type, Formulation, Application, and Region:

Type Outlook (Volume, Kilo tons; 2018-2026 And Revenue, USD Billion; 2018-2026)
• Protease
• Carbohydrase
• Lipase
• Polymerases and Nucleases
• Other Types

Source Outlook (Volume, Kilo tons; 2018-2026 And Revenue, USD Billion; 2018-2026)
• Microorganisms
• Plants
• Animals

Reaction Type Outlook (Volume, Kilo tons; 2018-2026 And Revenue, USD Billion; 2018-2026)
• Hydrolase
• Oxidoreductase
• Transferase
• Lyase
• Other Enzymes

Formulation Outlook (Volume, Kilo tons; 2018-2026 And Revenue, USD Billion; 2018-2026)
• Lyophilized powder
• Liquid
• Other (gel and granular forms)

Application Outlook (Volume, Kilo tons; 2018-2026 And Revenue, USD Billion; 2018-2026)
• Food & Beverage
• Household Care
• Bioenergy
• Pharmaceuticals and biotechnology
• Feed

To buy this report on the Enzymes market, click here @https://www.reportsanddata.com/checkout-form/1252

Regional Outlook (Volume, Kilo tons; 2018-2026 And Revenue, USD Billion; 2018-2026)
• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)

Further key findings from the report suggest
• With processed food gaining popularity, demand for enzymes is increasing. It adds longevity to food’s shelf life.
• Food and Beverages hold a market share of 24% in the year 2018 and is forecasted to hold a market share of 25% in the year 2026 with an annual growth rate of 6.0%
• Enzymes find its application in consumer products such as detergents. Even a molecule of the enzyme in the detergent can boost its ability to act on substrate molecules such as soil.
• On the basis of source, the market is segmented into microorganisms, plants, and animals. Microorganisms hold the major share as they are easily available and have low production costs.
• Microorganisms have a market share of 37% in the year 2018 and are forecasted to hold a market share of 38% in the year 2026 with 5.8% annual growth rate throughout the forecast period.
• Hydrolase has the largest market share of 24% in the year 2018 and is forecasted to hold a market share of 25% in the year 2026 with an annual growth rate of 6.0% throughout the forecast period.
• The U.S. is the major contributor in enzymes market owing to high demand in the food and beverage industry and a rising concern for health, coupled with a high preference for processed food will drive the market in this region.

To read the full report now, with industry-wide coverage, visit@ https://www.reportsanddata.com/report-detail/enzymes-market

Data Sources & Methodology:
Primary research is carried out through Email interactions, telephonic interviews, and one-on-one interviews and discussions to gain a crisp, clear, and accurate understanding of each market, category, segment, and sub-segment across geographies. Reports and Data has a strong global database comprising experts, participants, and veterans across a range of industries, verticals, sectors, and markets, through whom we validate our information/data and analysis results. A typical research interview fulfills the following functions: Provides competitive landscape, consumer trends, market growth trends, first-hand information, and analysis on market size, opportunities, outlook, etc.

Contact Info:
Name: John Watson
Email: Send Email
Organization: Reports And Data
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Phone: +1-212-710-1370
Website: https://www.reportsanddata.com/

Source URL: https://marketersmedia.com/enzymes-market-research-report-by-current-future-trends-and-industry-forecast-to-2026/88959261

Source: MarketersMedia

Release ID: 88959261

Styrene Maleic Anhydride Market Research Study Report 2020-2027 Analyzing Industry Top Players

Styrene Maleic Anhydride (SMA or SMAnh) Market was valued at USD Million in the year 2019 and is estimated to grow at a CAGR of to reach the valuation of USD XX Million in the year 2027.

New York, United States – May 28, 2020 /MarketersMedia/ —

Styrene Maleic Anhydride (SMA or SMAnh) is a synthetic polymer consisting of styrene and maleic anhydride monomers. The monomers are found to perfectly alternate, which makes it an active alternating copolymer and makes copolymerization possible with less than 50% maleic anhydride content. The polymer is produced by radical polymerization with an organic peroxide as the initiator.

The principal features of Styrene Maleic Anhydride Copolymer are that it is colorless and offers thermal resistance, specific reactivity of the anhydride groups, and high dimensional stability. It is a thermoplastic resin made by the copolymerization of styrene and maleic anhydride. It is also soluble in aqueous solutions. The rigid and thermal and chemical resistant plastic is used in small appliances, automobile parts, and other objects like food-service trays. The report looks at the market comprehensively to give a detailed account of the major products, end-user applications, regions, and manufacturers. It also considers the impact of the coronavirus pandemic to project its possible effects on the business in the forecast period.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.marketexpertz.com/sample-enquiry-form/1344

This is the latest report, covering the current COVID-19 scenario. The coronavirus pandemic has greatly affected every industry worldwide. It has brought along various changes in market conditions. The rapidly changing market scenario and the initial and future assessment of the impact are covered in the research report. The report discusses all major aspects of the market with expert opinions on the current status along with historical data.

The Styrene Maleic Anhydride (SMA or SMAnh) Market report mentions the estimation of the market size both for value and volume. Top-down and bottom-up approaches have been used by the analysts to estimate and validate the market size of the Styrene Maleic Anhydride (SMA or SMAnh) market, and also to forecast the size of the various other dependent submarkets. It includes the supply-demand ratio, Styrene Maleic Anhydride (SMA or SMAnh) market frequency, and key players of the market, driving factors, restraints, and challenges. The report also provides details regarding market revenue, sales, production, and manufacturing cost, which would help readers gain a better view of the market.

Leading Styrene Maleic Anhydride (SMA or SMAnh) manufacturers/companies operating at both regional and global levels:
Polyscope Polymers
TOTAL Cray Valley (TCV)
INEOS
Sinopec
Baoding Lucky Chemical
YINXIN Chemical
Kaixin Fine Chemical

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The segmentation included in the report is beneficial for readers to capitalize on the selection of appropriate segments for the Styrene Maleic Anhydride (SMA or SMAnh) sector and can help companies in deciphering the optimum business move to reach their desired business goals.

In market segmentation by types of Styrene Maleic Anhydride (SMA or SMAnh), the report covers-
A-SMA
R-SMA

In market segmentation by applications of the Styrene Maleic Anhydride (SMA or SMAnh), the report covers the following uses-
Automobile Instrument
Phase Solvent
Building Materials
Others

Buy Your Copy Now (Customized report delivered as per your specific requirement) @ https://www.marketexpertz.com/checkout-form/1344

Regional Outlook:
The regional segmentation includes the present and forecast demand for the Styrene Maleic Anhydride (SMA or SMAnh) Market in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It covers the individual application segments of the market in each region.

Key Chapters in the Global Styrene Maleic Anhydride (SMA or SMAnh) Market:
Chapter 1 analyzes the Styrene Maleic Anhydride (SMA or SMAnh) Introduction, product offerings, and scope, complete market overview, growth opportunities, market risks, driving forces, and others.
Chapter 2 presents a detailed study of the key manufacturers of Styrene Maleic Anhydride (SMA or SMAnh), along with sales, revenue, and the price of Styrene Maleic Anhydride (SMA or SMAnh).
Chapter 3 includes the competitive scenario among the major manufacturers and vendors.
Chapter 4 shows the global Styrene Maleic Anhydride (SMA or SMAnh) market by regions, clubbed with sales, revenue, and market share of Styrene Maleic Anhydride (SMA or SMAnh), for each region from 2016 to 2026.
Chapters 5, 6, 7, 8 and 9, study the market by region, by type, by application, and by manufacturers, with the sales, revenue, and market share included by key countries in these regions.

Read the full Research Report along with a table of contents, facts and figures, charts, graphs, etc. @ https://www.marketexpertz.com/report-detail/global-styrene-maleic-anhydride-sma-or-smanh-market-professional-survey-report-2018

Thank you for reading our report. For further details or to inquire about customization, please let us know, and we will offer you the report as per your needs.

Contact Info:
Name: John Watson
Email: Send Email
Organization: Market Expertz
Address: 40 Wall St. 28th floor New York City, NY 10005, NY 10005 United States
Phone: +1-800-819-3052
Website: https://www.marketexpertz.com/

Source URL: https://marketersmedia.com/styrene-maleic-anhydride-market-research-study-report-2020-2027-analyzing-industry-top-players/88958151

Source: MarketersMedia

Release ID: 88958151